May 26, 2021 | Advocacy
Multiple Sclerosis NZ received several reports from concerned patients regarding the ambiguity of the Special Authority Criteria for DMTs. With the support of Dr John Mottershead, Pharmac were approached for clarification.
Concern centred around whether bilateral aids qualify for use for the 100m walk for treatment renewal and qualification.
Pharmac have made the following amendment to the Special Authority Criteria to show that for continuation on DMT, a:
“Patient has had an EDSS score of 0 to 6.0 (inclusive) with or without the use of unilateral or bilateral aids at any time in the last six months (i.e. the patient has walked 100 metres or more with or without aids in the last six months)”
Multiple Sclerosis NZ are pleased that this clarification has been made with an amendment to the renewal criteria. Should any patients be experiencing further difficulties following this amendment we encourage you to contact MSNZ so we can assist in investigating or seeking further clarification.
Image from iStock.